ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $339,000 | -21.9% | 9,240 | -0.9% | 0.01% | -22.2% |
| Q2 2019 | $434,000 | -8.1% | 9,324 | -20.7% | 0.01% | -10.0% |
| Q1 2019 | $472,000 | -9.9% | 11,760 | +3.2% | 0.01% | -23.1% |
| Q4 2018 | $524,000 | -14.0% | 11,396 | -16.9% | 0.01% | +8.3% |
| Q3 2018 | $609,000 | +757.7% | 13,720 | +653.8% | 0.01% | +500.0% |
| Q2 2018 | $71,000 | -94.4% | 1,820 | -89.7% | 0.00% | -93.1% |
| Q1 2018 | $1,278,000 | +353.2% | 17,668 | +312.4% | 0.03% | +383.3% |
| Q4 2017 | $282,000 | -24.0% | 4,284 | -42.0% | 0.01% | -33.3% |
| Q3 2017 | $371,000 | -3.4% | 7,392 | -10.8% | 0.01% | 0.0% |
| Q2 2017 | $384,000 | -1.8% | 8,288 | -25.3% | 0.01% | -10.0% |
| Q1 2017 | $391,000 | +181.3% | 11,088 | 0.0% | 0.01% | +150.0% |
| Q4 2016 | $139,000 | – | 11,088 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $33,967,000 | 11.67% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $20,644,000 | 0.58% |
| Bellevue Group AG | 4,519,164 | $54,455,000 | 0.55% |
| Rhenman & Partners Asset Management AB | 622,267 | $7,498,000 | 0.53% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 47,534 | $573,000 | 0.21% |
| WASATCH ADVISORS LP | 3,274,360 | $39,456,000 | 0.16% |
| EMC Capital Management | 27,566 | $246,000 | 0.14% |
| PDT Partners, LLC | 120,828 | $1,456,000 | 0.10% |
| Virtus ETF Advisers LLC | 17,773 | $214,000 | 0.09% |
| Pinz Capital Management, LP | 15,300 | $184,000 | 0.08% |